國立高雄大學圖資館 |

登入

回首頁

Microbiota and dietary mediators in colon cancer prevention and treatment

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Microbiota and dietary mediators in colon cancer prevention and treatmentedited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy.
其他作者:	Pathak, Surajit.
出版者:	Singapore :Springer Nature Singapore :2024.
面頁冊數:	xiv, 367 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Colon (Anatomy)Cancer
電子資源:	https://doi.org/10.1007/978-981-96-0297-1
ISBN:	9789819602971$q(electronic bk.)

Microbiota and dietary mediators in colon cancer prevention and treatment
Microbiota and dietary mediators in colon cancer prevention and treatment[electronic resource] /edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy. - Singapore :Springer Nature Singapore :2024. - xiv, 367 p. :ill., digital ;24 cm.

1. Gut microbiota and its Importance in Health and Disease -- 2Recent Innovations in Probiotics and Prebiotics and Gut health -- 3. The Mechanistic Perspectives of Functional Foods - Probiotics and Prebiotics: A Focus on Colon Cancer and Human Health -- 4. Health Benefits of Probiotics and Prebiotics interaction -- 5. Genetically Engineered Probiotics and Potential in Therapeutic Applications -- 6. Probiotic, Prebiotic, and Gut-Brain Connection in Cancer Development -- 7. The influence of prebiotics and probiotics in colorectal cancer treatment -- 8. ROLE OF DIETARY PHYTOCHEMICALS IN GUT DYSBIOSIS: IMPLICATIONS IN COLON CANCER PREVENTION AND TREATMENT -- 9. Probiotics: Immune responses and gut microbiome -- 10. Probiotics Formulation and Cancer Nano-vaccines in GI-Tract Cancer -- 11. Association between Gut Microbiome and Liver and Colon Cancer -- 12. Prebiotic Fortification: Millets in Building Resilience Against Colon Cancer -- 13. Probiotics in Colorectal Cancer: An Emphasis on Immunomodulatory and Anti-Cancer Properties -- 14. Cancer Risk in Alterations of Prebiotics -- 15. Priming the Nutrition-Gut-Immuno-Oncology Axis -- 16. Probiotics & Prebiotics in IBS. Therapeutic role of probiotics & prebiotics in irritable bowel syndrome.

The book discusses the role of gut microbiome composition in colorectal cancer progression, linking intestinal inflammation, tumorigenesis and anti-cancer immune responses. Chapters delve into various areas, including the mechanisms of action of probiotics and prebiotics (such as Lactobacillus and Bifidobacterium strains, and fructans and galactans, respectively), functional foods such as α-carotene, β-carotene, lutein, β-cryptoxanthin, fucoxanthin, isothiocyanates, flavonoids, probiotics, fibre and omega-3. Lycopene, β-cryptoxanthin, and fucoxanthin. Dietary phytochemicals such as polyphenols (curcumin, gingerol, ferulic acid (FA) and hydroxytyrosol); alkaloids (piperine, and protopine); terpenoids (artemisinin, and astaxanthin); iridoid glycoside (picroside II, and morroniside); and flavonoid (quercetin) on cancer, immune responses, and the gut microbiome. It examines the interaction and influence of prebiotics and probiotics in colorectal cancer treatment, their use in managing chemotherapy-related gastrointestinal problems, and their potential as adjuvants. The book also investigates how these gut microbes are associated with tumor progression and anti-cancer treatment efficacy. This knowledge can be used to develop biomarkers that predict immunotherapy effectiveness and improve treatment outcomes through modulation. This book provides a comprehensive update on the latest research and clinical applications in the field, offering valuable insights into the complex interplay between probiotics, the gut microbiome, and colorectal cancer. It serves as an invaluable resource for healthcare professionals, researchers, and students seeking to understand this dynamic area of study.

ISBN: 9789819602971$q(electronic bk.)

Standard No.: 10.1007/978-981-96-0297-1doiSubjects--Topical Terms:

988801
Colon (Anatomy)
--Cancer

LC Class. No.: RC280.C6

Dewey Class. No.: 616.994347

Microbiota and dietary mediators in colon cancer prevention and treatment
LDR:03989nmm a2200325 a 4500 001 674971
003 DE-He213
005 20250217115407.0
006 m d
007 cr nn 008maaau
008 250624s2024 si s 0 eng d
020 $a 9789819602971$q(electronic bk.)
020 $a 9789819602964$q(paper)
024 7 $a 10.1007/978-981-96-0297-1 $2 doi
035 $a 978-981-96-0297-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.C6
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.994347 $2 23
090 $a RC280.C6 $b M626 2024
245 0 0 $a Microbiota and dietary mediators in colon cancer prevention and treatment $h [electronic resource] / $c edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xiv, 367 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Gut microbiota and its Importance in Health and Disease -- 2Recent Innovations in Probiotics and Prebiotics and Gut health -- 3. The Mechanistic Perspectives of Functional Foods - Probiotics and Prebiotics: A Focus on Colon Cancer and Human Health -- 4. Health Benefits of Probiotics and Prebiotics interaction -- 5. Genetically Engineered Probiotics and Potential in Therapeutic Applications -- 6. Probiotic, Prebiotic, and Gut-Brain Connection in Cancer Development -- 7. The influence of prebiotics and probiotics in colorectal cancer treatment -- 8. ROLE OF DIETARY PHYTOCHEMICALS IN GUT DYSBIOSIS: IMPLICATIONS IN COLON CANCER PREVENTION AND TREATMENT -- 9. Probiotics: Immune responses and gut microbiome -- 10. Probiotics Formulation and Cancer Nano-vaccines in GI-Tract Cancer -- 11. Association between Gut Microbiome and Liver and Colon Cancer -- 12. Prebiotic Fortification: Millets in Building Resilience Against Colon Cancer -- 13. Probiotics in Colorectal Cancer: An Emphasis on Immunomodulatory and Anti-Cancer Properties -- 14. Cancer Risk in Alterations of Prebiotics -- 15. Priming the Nutrition-Gut-Immuno-Oncology Axis -- 16. Probiotics & Prebiotics in IBS. Therapeutic role of probiotics & prebiotics in irritable bowel syndrome.
520 $a The book discusses the role of gut microbiome composition in colorectal cancer progression, linking intestinal inflammation, tumorigenesis and anti-cancer immune responses. Chapters delve into various areas, including the mechanisms of action of probiotics and prebiotics (such as Lactobacillus and Bifidobacterium strains, and fructans and galactans, respectively), functional foods such as α-carotene, β-carotene, lutein, β-cryptoxanthin, fucoxanthin, isothiocyanates, flavonoids, probiotics, fibre and omega-3. Lycopene, β-cryptoxanthin, and fucoxanthin. Dietary phytochemicals such as polyphenols (curcumin, gingerol, ferulic acid (FA) and hydroxytyrosol); alkaloids (piperine, and protopine); terpenoids (artemisinin, and astaxanthin); iridoid glycoside (picroside II, and morroniside); and flavonoid (quercetin) on cancer, immune responses, and the gut microbiome. It examines the interaction and influence of prebiotics and probiotics in colorectal cancer treatment, their use in managing chemotherapy-related gastrointestinal problems, and their potential as adjuvants. The book also investigates how these gut microbes are associated with tumor progression and anti-cancer treatment efficacy. This knowledge can be used to develop biomarkers that predict immunotherapy effectiveness and improve treatment outcomes through modulation. This book provides a comprehensive update on the latest research and clinical applications in the field, offering valuable insights into the complex interplay between probiotics, the gut microbiome, and colorectal cancer. It serves as an invaluable resource for healthcare professionals, researchers, and students seeking to understand this dynamic area of study.
650 0 $a Colon (Anatomy) $x Cancer $x Nutritional aspects. $3 988801
650 0 $a Colon (Anatomy) $x Cancer $x Microbiology. $3 988802
650 0 $a Colon (Anatomy) $x Cancer $x Prevention. $3 728157
650 0 $a Colon (Anatomy) $x Cancer $x Treatment. $3 710579
650 1 4 $a Microbiology. $3 192943
650 2 4 $a Biological Sciences. $3 503847
650 2 4 $a Cancer Biology. $3 920982
650 2 4 $a Cancer Prevention. $3 965914
650 2 4 $a Cancer Therapy. $3 915060
700 1 $a Pathak, Surajit. $3 880272
700 1 $a Banerjee, Antara. $3 880273
700 1 $a Duttaroy, Asim K. $3 225248
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-96-0297-1
950 $a Medicine (SpringerNature-11650)